5 June 2014 in Journal of Clinical Research in Pediatric Endocrinology
The aim of this study was to investigate the epidemiology of congenital hypothyroidism (CH) among newborns in Markazi Province, Iran. This cross-sectional study was conducted from 2006 to 2012. Blood samples were taken between 3 to 5 days after birth from the heel. Thyroid stimulating hormone (TSH) was tested using the enzyme-linked immunosorbent assay method and was employed as the screening test. Newborns with abnormal screening results (TSH >5 mIU/L) were re-examined. The data were analyzed using SPSS. A total of 127 112 infants were screened. Of these, 51.2% were male and 48.8% were female. The coverage rate of the screening program was 100%. Of 6102 recalled subjects (re-call rate 4.8%), 414 cases with CH were detected, yielding a CH prevalence of 1:307 (female:male ratio 1:0.95). The prevalence of permanent and transient CH was 1:581 and 1:628, respectively. This study reveals that the prevalence of CH is higher compared to worldwide levels. Comprehensive and complementary studies for recognizing related risk factors should be a priority for health system research in this province.
9 May 2013 in Saudi Pharmaceutical Journal
Background and aims Currently, there is no widely accepted evidence-based pharmacotherapy regime for the treatment of psychostimulant dependence. Yet, different pharmacological approaches have been tried in the treatment of MA addiction. The present study was conducted to compare efficiency of methylphenidate which is relatively easily accessible in our country, with resperidone for this purpose. Methods: Eighty-six patients with MA dependence according to criteria defined by DSM IV-TR were divided into two groups. Patients in group R were given oral resperidone 1 mg daily for 1 week; then 2 mg daily in a divided dose for 3 weeks. Patients in group M were given oral methylphenidate 10 mg daily for 2 weeks, 7.5 mg daily for 1 week, then 5 mg daily for 1 week. They were evaluated for drug craving, psychological, neurologic and somatic symptoms at the start and end of the study. Findings: Both drugs were useful for lowering drug craving in patients; however resperidone was more effective (6.31 ± 8.31 vs.19.6 ± 12.45 cravings per week, respectively). The effects of resperidone were more notable in lowering frequency and intensity of psychiatric, neurologic, cardiac and somatic symptoms of the patients after discontinuation of MA abuse; however methylphenidate was effective too; though with a lower potency. Conclusion: The present study confirmed that both methylphenidate and resperidone can successfully be used for treatment of MA dependence, in order to reduce drug craving and psychological, neurologic, and somatic problems in patients. However, the efficacy of methylphenidate was estimated to be less than that of resperidone for this purpose.
1 April 2024 in Clinical Case Reports
Key Clinical Message: A high risk diabetic foot ulcer is treated by ozone therapy and collagen powder. The goal of this study was to report a high risk case, treated by ozone therapy, and collagen powder. Ozone therapy and collagen powder can improve healing process of diabetic foot ulcers. This case report presents a successful nonsurgical outpatient approach for managing a high‐risk diabetic foot ulcer with tendon exposure in an older adult with uncontrolled diabetes mellitus and severe heart failure. Due to the patient's comorbidities, surgical intervention was not an option, leading to the utilization of ozone therapy, collagen powder, and Phenytoin ointment. The significance of this case lies in the treatment of a high‐risk foot ulcer through a nonsurgical approach, considering the patient's uncontrolled diabetes and severe heart failure. Diabetic foot ulcers (DFUs) are debilitating and life‐threatening complications, often resulting in amputations, socio‐psychological burdens, and lifestyle changes. Conventional treatment methods have shown limited success, necessitating the exploration of new and innovative approaches. The use of ozone therapy has emerged as a potential treatment, but its safety and efficacy in DFUs require further investigation. The positive outcomes observed in this case report suggest that ozone therapy may be a viable option for treating DFUs, and further studies are recommended to evaluate its effectiveness.
10 July 2023 in Jundishapur Journal of Natural Pharmaceutical Products
Background: Diabetes is a chronic metabolic disease that impairs plasma lipid levels and prone a person to cardiovascular diseases. Since standard therapies in diabetes control fail in many patients, using herbal medicines in these patients has been considered. Objectives: The present study aimed to evaluate the effect of Nigella sativa (NS) seed powder on blood sugar and fat profile in type 2 diabetic patients. Methods: Eighty patients with type 2 diabetes were recruited and randomly assigned into control and experimental groups. The experimental group received a capsule containing Nigella sativa seed powder for two months, and the control group received a placebo. Blood glucose and lipid profile data were statistically analyzed at the end of two months. This study was conducted in diabetic clinic of Khomein City during the 2019 - 2020 year. The groups were compared using a repeated measures analysis of variance (ANOVA) test. Results: The mean age of patients was 53.82 in the experimental group and 55.12 in the control group. In comparison between the two measurements before and after the interventions, the variables glycosylated hemoglobin (HbA1c), cholesterol (Chol), and high-density lipoprotein (HDL) showed a statistically significant difference (P = 0.0001). The interactive effect between the control and intervention groups before and after the interventions was statistically significant for the postprandial glucose (PPG) variable (P = 0.035). Conclusions: The results of our study showed that the consumption of NS seed in diabetic patients could change the fat profile and reduce hemoglobin HbA1c, which indicated that Nigella sativa seed had been effective in reducing blood sugar over time.